MARKET

SLS

SLS

SELLAS LIFE SCIE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.090
+0.030
+0.74%
After Hours: 4.100 +0.01 +0.24% 17:05 12/13 EST
OPEN
4.070
PREV CLOSE
4.060
HIGH
4.140
LOW
3.940
VOLUME
297.63K
TURNOVER
--
52 WEEK HIGH
89.50
52 WEEK LOW
3.673
MARKET CAP
19.93M
P/E (TTM)
-0.0016
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SLS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SLS News

  • SELLAS Life Sciences Group, Inc. (SLS) CEO Angelos Stergiou at 12th Annual LD Micro Main Event Conference (Transcript)
  • Seeking Alpha - Transcript.2d ago
  • 12th Annual LD Micro Event (Stream Link)
  • Benzinga.2d ago
  • SELLAS to Present at the 12th Annual LD Micro Main Event
  • GlobeNewswire.12/04 13:00
  • NTNX, DKS among premarket gainers
  • Seeking Alpha - Article.11/26 14:26

More

Industry

Pharmaceuticals
+0.25%
Pharmaceuticals & Medical Research
+0.01%

Hot Stocks

Name
Price
%Change

About SLS

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system.
More

Webull offers Sellas Life Sciences Group Inc (SLS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.